Research Study for Cocaine-Dependent Individuals. Comp up to $2400

Research Study for Cocaine-Dependent Individuals. Comp up to $2400

CONFIDENTIAL Research Study at Weill Cornell Medicine/ New York Presbyterian Hospital

The study is a phase I dose-ranging, placebo-controlled, double-blind study assessing the safety and preliminary efficacy of a vaccine for cocaine dependence. It is a 32-week research study which includes 6 doses of an investigational vaccine or placebo.

Qualified participants may receive study-related tests and individual counseling with a behavioral therapist.

Compensation for participation: Up to $2400

Principals only. Recruiters, please don't contact this job poster.

do NOT contact us with unsolicited services or offers